WIreless Monitoring and Financial Incentives for Uncontrolled HYpertension (WIFHY) Study (WIFHY)
Hypertension

About this trial
This is an interventional prevention trial for Hypertension focused on measuring Hypertension, Wireless Home Blood Pressure Monitoring, Medication Adherence, Medication Titration, Financial Incentives, Ambulatory Blood Pressure Monitoring
Eligibility Criteria
Inclusion Criteria:
- Known hypertensive patients on at least one anti-hypertensive medication
- SBP more than or equal to 140 mmHg or DBP more than or equal to 90 mmHg for patients without diabetes, SBP more than or equal to 140 mmHg or DBP more than or equal to 85 mmHg for patients with diabetes, as verified by the average of the last 2 of 3 BP readings taken, on the day of polyclinic visit, at 3 minutes interval using the Omron HEM-7130
- Aged between 21 to 70 years of age;
- Singaporean citizens or Permanent Residents;
- Able to converse in English or Mandarin;
- Has a compatible smartphone (iOS Versions 8.0 and higher or Android Versions 5.0 and higher) with data plan or regular Wi-Fi access
- Ability to perform self-monitoring of BP as assessed by the CRC
- Expecting to be a patient of Bedok or Marine Parade Polyclinics for the duration of the trial
Exclusion Criteria:
- SBP equal or greater than 180mmHg or DBP equal or greater than 110mmHg, as verified by the average of the last 2 of 3 BP readings taken, on the day of polyclinic visit, at 3 minutes interval using the Omron HEM-7130
- pregnancy
- clinically unstable heart failure
- advanced kidney disease, i.e. eGFR < 30 ml/min
- known liver disease
- Atrial Fibrillation
- underwent Double Mastectomy
- any other major debilitating disease or mental illness that precludes validity of informed consent or would result in the patient being unable to take their BP independently.
- started on angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin- receptor blockers (ARB) within the last 3 months
- on Warfarin or anti-coagulants (e.g. NOACs: Novel Oral Anticoagulants)
- known allergy to epoxy resin
- discharged from hospital within the last 3 months for complications related to hypertension
- newly referred to Specialist Outpatient Clinics (SOCs) or on follow-up for complications related to hypertension
- severe or overt macro albuminuria (urine ACR>30mg/mmol or PCR>0.5)
- confirmed glomerulonephritis
- living in a household where another member has been recruited into the trial
Sites / Locations
- Marine Parade Polyclinic
- Bedok Polyclinic
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Usual Care
Wireless HBPM System
Wireless HBPM System and Incentives
Usual care from SingHealth Polyclinics which includes non-wireless HBPM. In addition, participants will receive a medication event monitoring system and will be on ambulatory blood pressure monitoring at baseline and Month 6.
Usual care from SingHealth Polyclinics with wireless HBPM system. In addition, participants will receive a medication event monitoring system and will be on ambulatory blood pressure monitoring at baseline and Month 6.
Usual care from SingHealth Polyclinics with wireless HBPM system and BP monitoring incentives. In addition, participants will receive a medication event monitoring system and will be on ambulatory blood pressure monitoring at baseline and Month 6.